Erratum: computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for plasmodium falciparum and P. vivax (Antimicrobial Agents and Chemotherapy (2020) 64:9 (e02041-19) DOI: 10.1128/AAC.02041-19)

Letícia Tiburcio Ferreira, Juliana Rodrigues, Gustavo Capatti Cassiano, Tatyana Almeida Tavella, Kaira Cristina Peralis Tomaz, Djane Clarys Baia-Da-Silva, Macejane Ferreira Souza, Marilia Nunes do Nascimento Lima, Melina Mottin, Ludimila Dias Almeida, Juliana Calit, Maria Carolina Silva de Barros Puça, Gisely Cardoso Melo, Daniel Youssef Bargieri, Stefanie Costa Pinto Lopes, Marcus Vinicius Guimarães Lacerda, Elizabeth Bilsland, Per Sunnerhagen, Bruno Junior Neves, Carolina Horta AndradePedro Vitor Lemos Cravo, Fabio Trindade Maranhão Costa

Research output: Contribution to journalComment/debatepeer-review

Abstract

Volume 64, no. 9, e02041-19, 2020, https://doi.org/10.1128/AAC.02041-19. Page 1: This article was published on 20 August 2020 with a standard copyright line (“

Original languageEnglish
Article numbere01843
Pages (from-to)e01843
Number of pages1
JournalAntimicrobial Agents and Chemotherapy
Volume64
Issue number11
DOIs
Publication statusPublished - Oct 2020

Fingerprint

Dive into the research topics of 'Erratum: computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for plasmodium falciparum and P. vivax (Antimicrobial Agents and Chemotherapy (2020) 64:9 (e02041-19) DOI: 10.1128/AAC.02041-19)'. Together they form a unique fingerprint.

Cite this